While NASH is initiated by hepatic lipotoxicity, NASH progression is mainly driven by impaired KC homeostasis and subsequent liver inflammation (Cai et al., 2019). This evidence concerns the gene CALCA and metabolic dysfunction-associated steatohepatitis.